Webstar Technology Group, Inc. (WBSR)
OTCMKTS · Delayed Price · Currency is USD
0.0400
+0.0020 (5.26%)
Aug 1, 2025, 10:38 AM EDT

Ligand Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
-4.34-4.5-0.91-31.02-2.63-1.35
Upgrade
Other Amortization
--0000
Upgrade
Stock-Based Compensation
---16.071.41-
Upgrade
Other Operating Activities
4.034.08-13.9--
Upgrade
Change in Accounts Receivable
----00
Upgrade
Change in Accounts Payable
-00-0.020-00.04
Upgrade
Change in Other Net Operating Assets
0.170.30.80.881.061.03
Upgrade
Operating Cash Flow
-0.14-0.11-0.13-0.17-0.17-0.27
Upgrade
Short-Term Debt Issued
-0.110.140.170.170.18
Upgrade
Total Debt Issued
0.170.110.140.170.170.18
Upgrade
Short-Term Debt Repaid
---0---0
Upgrade
Total Debt Repaid
-0.03--0---0
Upgrade
Net Debt Issued (Repaid)
0.140.110.130.170.170.18
Upgrade
Issuance of Common Stock
-----0.06
Upgrade
Financing Cash Flow
0.140.110.130.170.170.24
Upgrade
Net Cash Flow
0-0-0-0-0-0.04
Upgrade
Levered Free Cash Flow
-3.44-3.40.135.370.820.23
Upgrade
Unlevered Free Cash Flow
-3.39-3.350.185.40.820.23
Upgrade
Change in Net Working Capital
3.243.1-0.7-0-1.05-1.08
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.